US biotech Vanda Pharmaceuticals (Nasdaq: VNDA) has announced that the American medicines regulator removed a partial ...

The US Food and Drug Administration has approved Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19 ...

A Netherlands-linked biotech company developing targeted protein degraders designed to remove disease-relevant membrane ...

The UK’s BioIndustry Association (BIA) today released its report, From innovation to impact: unlocking patient access to ...

The US Food and Drug Administration (FDA) has announced that Tracy Beth Høeg has been appointed acting director of the Center ...

Accession Therapeutics, a UK clinical-stage biopharmaceutical company developing next generation cancer immunotherapies, ...

A new Australian biotech, Evinco Therapeutics, has launched in Melbourne to advance immune-based treatments for Alzheimer’s ...

US rare diseases focused biotech Capricor Therapeutics shares closed up 371% at $29.96, having leapt a staggering 500% ...

Dutch biotech Laigo Bio has launched with 11.5 million euros ($12.7 million) in seed financing to progress its SureTAC ...

Bristol Myers Squibb (NYSE: BMY) is bringing fresh participants into its Phase III ADEPT-2 trial of Cobenfy ...

US oncology specialist Crescent Biopharma has announced an exclusive partnership with China’s Sichuan Kelun-Biotech ...

IDA Ireland has released a new whitepaper setting out how the country intends to strengthen its role as a global center for ...